| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 10/01/2014 | EP2782914A1 Method for producing substituted 5-fluoro-1h-pyrazolopyridines |
| 10/01/2014 | EP2782903A1 Novel pyrrolidine derivatives as inhibitors of cathepsin |
| 09/30/2014 | US8846906 5HT2C receptor modulators |
| 09/30/2014 | US8846696 Purine derivatives |
| 09/30/2014 | US8846693 Optionally substituted pyrazolo[3,4-d]pyrimidine-4,6-diones |
| 09/30/2014 | US8846681 Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
| 09/30/2014 | US8846401 Promoters exhibiting endothelial cell specificity and methods of using same |
| 09/30/2014 | CA2664579C 2-aminocarbonyl-pyridine derivatives |
| 09/30/2014 | CA2535489C Antibodies against factor viii with modified glycosylation in the variable region |
| 09/25/2014 | WO2014153226A1 Arginine methyltransferase inhibitors and uses thereof |
| 09/25/2014 | WO2014153172A1 Pyrazole derivatives as prmt1 inhibitors and uses thereof |
| 09/25/2014 | WO2014153089A1 Cd14+ cell compositions and methods of using same |
| 09/25/2014 | WO2014153044A1 Treatment of patients with hyponatremia and cardiac disease |
| 09/25/2014 | WO2014152621A1 P2x7 modulators |
| 09/25/2014 | WO2014152564A1 Methods of acute restoration of vascular compliance |
| 09/25/2014 | WO2014152270A1 Salt of omecamtiv mecarbil and process for preparing salt |
| 09/25/2014 | WO2014152236A1 Heterocyclic compounds and their uses |
| 09/25/2014 | WO2014152198A1 Heterocyclic compounds and their uses |
| 09/25/2014 | WO2014151011A1 Selective inhibitor of angiotensin ii |
| 09/25/2014 | WO2014150873A1 Sequestrants of advanced glycation end product (age) precursors |
| 09/25/2014 | WO2014150395A1 Anti-pcsk9 compounds and methods for the treatment and/or prevention of cardiovascular diseases |
| 09/25/2014 | WO2014149979A1 Treatment of peripheral vascular disease using protein solutions |
| 09/25/2014 | WO2014149270A1 Treatment of pain using protein solutions |
| 09/25/2014 | WO2014149198A1 Compositions and methods of using the compositions for plaque softening |
| 09/25/2014 | WO2014148489A1 Cyclic peptide |
| 09/25/2014 | WO2014148455A1 Terpenoid derivative |
| 09/25/2014 | WO2014147204A1 Heteroaryl substituted indazoles |
| 09/25/2014 | WO2014146747A1 Piperazine derivatives as fasn inhibitors |
| 09/25/2014 | US20140288266 Synthesis of Cyclosporin Analogs |
| 09/25/2014 | US20140288161 Urocortin-iii and uses thereof |
| 09/25/2014 | US20140288122 Method for inhibiting platelet aggregation |
| 09/25/2014 | US20140288114 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 09/25/2014 | US20140287495 Methods of Inducing Differentiation of Stem Cells |
| 09/24/2014 | EP2781599A1 Nucleic acid fragment binding to target protein |
| 09/24/2014 | EP2781521A1 Novel spiroindoline compound, and medicinal agent comprising same |
| 09/24/2014 | EP2781505A1 Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates |
| 09/24/2014 | EP2780371A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for regulating the fluid balance in a patient having a chronic or acute disease |
| 09/24/2014 | EP2780370A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation |
| 09/24/2014 | EP2780369A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute condition |
| 09/24/2014 | EP2780367A1 Antibodies for molecular imaging of vulnerable plaques in atherosclerosis |
| 09/24/2014 | EP2780344A1 Thieno [2, 3 - c]pyrazoles for use as potassium channel inhibitors |
| 09/24/2014 | EP2780343A1 Thieno- and furo - pyrimidines and pyridines, useful as potassium channel inhibitors |
| 09/24/2014 | EP2780342A1 Aminoquinazoline derivatives and their salts and methods of use |
| 09/24/2014 | EP2780327A1 Polymorphic forms of ivabradine hydrochloride |
| 09/24/2014 | EP2779839A1 Products for oral administration comprising extracts of punica granatum (pomegranate), intended for a pet, and applications of same |
| 09/23/2014 | US8841261 Functional powdery product |
| 09/23/2014 | US8841254 Method for treatment of anxiety |
| 09/23/2014 | CA2629738C Novel indolizine derivatives, method for preparing same and therapeutic compositions comprising same |
| 09/23/2014 | CA2534474C Methods for treating cardiovascular disease using a soluble ctla4 molecule |
| 09/23/2014 | CA2398995C Lipid hydrolysis therapy for atherosclerosis and related diseases |
| 09/18/2014 | WO2014145118A1 Resorufin derivatives for treatment of oxidative stress disorders |
| 09/18/2014 | WO2014145037A1 Methods and compositions for enhancing oxygen levels in tissues |
| 09/18/2014 | WO2014143625A1 Budiodarone formulations |
| 09/18/2014 | WO2014143610A1 Pyrrolotriazines as potassium ion channel inhibitors |
| 09/18/2014 | WO2014143609A1 Isoquinolines as potassium ion channel inhibitors |
| 09/18/2014 | WO2014143608A1 Phthalazines as potassium ion channel inhibitors |
| 09/18/2014 | WO2014143607A1 Pyrrolopyridazines as potassium ion channel inhibitors |
| 09/18/2014 | WO2014143606A1 Pyrrolotriazines as potassium ion channel inhibitors |
| 09/18/2014 | WO2014142780A1 Methods of treating, reducing the incidence of, and/or preventing ischemic events |
| 09/18/2014 | WO2014142291A1 Hydrate of fluorine compound, and crystals thereof |
| 09/18/2014 | WO2014142290A1 Pyrazole-amide compound and medicinal uses therefor |
| 09/18/2014 | WO2014142182A1 Monoclonal antibody inhibiting enzymatic activity of endothelial lipase |
| 09/18/2014 | WO2014142127A1 Phenylxanthene derivative |
| 09/18/2014 | WO2014140695A1 Solid oral formulation of a pyrrolidine substituted flavone compound |
| 09/18/2014 | WO2014140631A1 Prx933 (prx-00933), a 5ht2c agonist, for use in the treatment of hypertension |
| 09/18/2014 | WO2014140313A1 Macrocyclic salt-inducible kinase inhibitors |
| 09/18/2014 | WO2014140284A1 Use of linagliptin in cardio- and renoprotective antidiabetic therapy |
| 09/18/2014 | WO2014140186A1 Oxindole derivatives carrying an oxetane substituent and use thereof for treating vasopressine-related diseases |
| 09/18/2014 | WO2014140078A1 Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (cyano-methyl)-amides inhibitors of cathepsin c |
| 09/18/2014 | WO2014140065A1 N-(4-(azaindazol-6-yl)-phenyl)-sulfonamides and their use as pharmaceuticals |
| 09/18/2014 | WO2014139894A1 Homoarginine as therapeutic for the reduction of myocardial remodeling |
| 09/18/2014 | WO2014139882A1 Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
| 09/18/2014 | WO2014139443A1 Low immunogenicity human cell and preparation method therefor |
| 09/18/2014 | WO2014139063A1 Black medical soybean food obtained by immersing black soybeans in life-cultivating and health-care vinegar medical tea to carry out biological fermentation |
| 09/18/2014 | WO2014139014A1 Methods and compositions for the inhibition of vascular endothelial growth factor activity and vascular permeability |
| 09/18/2014 | US20140275545 8-carboxamido-2,6-methano-3-benzazocines |
| 09/18/2014 | US20140275479 Specific binding agents of human angiopoeitin-2 |
| 09/18/2014 | US20140275115 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 09/18/2014 | US20140271637 Methods of administering anti-tnfalpha antibodies |
| 09/17/2014 | EP2778223A1 Vascular progenitor cell sheet derived from induced pluripotent stem cells, and production method therefor |
| 09/17/2014 | EP2778156A1 Phenoxypyridinylamide derivatives and their use in the treatment of PDE4 mediated disease states |
| 09/17/2014 | EP2777701A1 Composition for preventing the occurrence of a cardiovascular event in multiple risk patient comprising the ethyl ester of all-cis-5,8,11,14,17-icosapentaenoic acid |
| 09/17/2014 | EP2776442A1 [1, 2, 3]triazolo [4, 5 -d]pyrimidine derivatives as agonists of the cannabinoid receptor 2 |
| 09/17/2014 | EP2776407A1 Modulators of the g protein-coupled mas receptor and the treatment of disorders related thereto |
| 09/17/2014 | EP2776405A1 2-thiopyrimidinones |
| 09/17/2014 | EP2776402A1 Meldrum 's acid, barbituric acid and pyrazolone derivatives substituted with hydroxylamine as hno donors |
| 09/17/2014 | EP2776058A1 Apotransferrin for the treatment of brain stroke |
| 09/17/2014 | EP2776057A1 Methods of cardiac repair |
| 09/17/2014 | EP2776028A1 3,4-di-substituted pyridine compound, methods of using and compositions comprising the same |
| 09/16/2014 | US8835653 Chlorothiophene-isoxazoles as inhibitors of coagulation factors Xa and thrombin |
| 09/16/2014 | US8835631 Therapeutic agent for cerebral infarction |
| 09/16/2014 | US8835435 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 09/16/2014 | US8835434 Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 09/16/2014 | US8834902 Biodegradable supporting device |
| 09/16/2014 | US8834897 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 09/16/2014 | CA2781066C Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use |
| 09/16/2014 | CA2656608C Compositions and methods for preventing or treating cardiovascular diseases in felines with hyperthyroidism |
| 09/16/2014 | CA2536827C Use of nitrite salts for the treatment of cardiovascular conditions |
| 09/16/2014 | CA2434050C Herbal composition for angina pectoris, method to prepare same and uses thereof |
| 09/12/2014 | WO2014138682A1 Compositions and methods for cardiac tissue repair |